Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 250

1.

NB-002, a novel nanoemulsion with broad antifungal activity against dermatophytes, other filamentous fungi, and Candida albicans.

Pannu J, McCarthy A, Martin A, Hamouda T, Ciotti S, Fothergill A, Sutcliffe J.

Antimicrob Agents Chemother. 2009 Aug;53(8):3273-9. doi: 10.1128/AAC.00218-09. Epub 2009 May 11.

2.

Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.

Croxtall JD, Plosker GL.

Drugs. 2009;69(3):339-59. doi: 10.2165/00003495-200969030-00009. Review.

PMID:
19275277
4.

The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi.

Myc A, Vanhecke T, Landers JJ, Hamouda T, Baker JR Jr.

Mycopathologia. 2002;155(4):195-201.

PMID:
12650595
5.

Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor.

Lopes G, Pinto E, Andrade PB, Valentão P.

PLoS One. 2013 Aug 12;8(8):e72203. doi: 10.1371/journal.pone.0072203. eCollection 2013.

7.

An evaluation of the in vitro activity of terbinafine.

Jessup CJ, Ryder NS, Ghannoum MA.

Med Mycol. 2000 Apr;38(2):155-9.

PMID:
10817232
8.

In vitro antifungal activity of Polyporaceae against yeasts and dermatophytes.

Steinmetz MD, Rascol JP, Régli P, Gargadennec A, Andary C.

Mycoses. 1995 Jul-Aug;38(7-8):305-9.

PMID:
8559195
9.

A chemically modified tetracycline (CMT-3) is a new antifungal agent.

Liu Y, Ryan ME, Lee HM, Simon S, Tortora G, Lauzon C, Leung MK, Golub LM.

Antimicrob Agents Chemother. 2002 May;46(5):1447-54.

10.

In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.

Tamura T, Asahara M, Yamamoto M, Yamaura M, Matsumura M, Goto K, Rezaei-Matehkolaei A, Mirhendi H, Makimura M, Makimura K.

Microbiol Immunol. 2014 Jan;58(1):1-8. doi: 10.1111/1348-0421.12109.

11.

In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.

Uchida K, Nishiyama Y, Yokota N, Yamaguchi H.

J Antibiot (Tokyo). 2000 Oct;53(10):1175-81.

12.

Antifungal activities of seven West African Combretaceae used in traditional medicine.

Baba-Moussa F, Akpagana K, Bouchet P.

J Ethnopharmacol. 1999 Sep;66(3):335-8.

PMID:
10473181
13.

In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.

Li RY, Wan Z, Wang AP, Shen YN, Lu CM, Li M, Xi LY, Liu WD, Zeng FQ.

Mycoses. 2004 Oct;47(9-10):402-6.

PMID:
15504124
14.

In vitro antifungal activity of N,N-phenyl-1,2,3,4-thiatriazole-5-yl-2,4-beta-resorcylcarbothioamide.

Krajewska-Kułak E, Niewiadomy A, Łukaszuk C, Matysiak J, Kostecka M.

Arzneimittelforschung. 2003;53(9):668-75.

PMID:
14558442
15.

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.

Tawara S, Ikeda F, Maki K, Morishita Y, Otomo K, Teratani N, Goto T, Tomishima M, Ohki H, Yamada A, Kawabata K, Takasugi H, Sakane K, Tanaka H, Matsumoto F, Kuwahara S.

Antimicrob Agents Chemother. 2000 Jan;44(1):57-62.

16.

Antifungal activities of different extracts of marine macroalgae against dermatophytes and Candida species.

Guedes EA, Araújo MA, Souza AK, de Souza LI, de Barros LD, Maranhão FC, Sant'Ana AE.

Mycopathologia. 2012 Sep;174(3):223-32. doi: 10.1007/s11046-012-9541-z. Epub 2012 Apr 22.

PMID:
22528741
17.

In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.

Chadeganipour M, Nilipour S, Havaei A.

Mycoses. 2004 Dec;47(11-12):503-7.

PMID:
15601457
18.

Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.

Herreros E, Martinez CM, Almela MJ, Marriott MS, De Las Heras FG, Gargallo-Viola D.

Antimicrob Agents Chemother. 1998 Nov;42(11):2863-9.

19.

In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses.

Koga H, Tsuji Y, Inoue K, Kanai K, Majima T, Kasai T, Uchida K, Yamaguchi H.

J Infect Chemother. 2006 Jun;12(3):163-5.

PMID:
16826352
20.

Antifungal activities and cytotoxicity studies of six new azasordarins.

Herreros E, Almela MJ, Lozano S, Gomez de las Heras F, Gargallo-Viola D.

Antimicrob Agents Chemother. 2001 Nov;45(11):3132-9.

Items per page

Supplemental Content

Write to the Help Desk